NEUROCOGNITIVE FUNCTION (NCF) OUTCOMES OF RTOG FOUNDATION 3508: A PHASE 3 TRIAL OF ABT-414 WITH CONCURRENT CHEMORADIATION AND ADJUVANT TEMOZOLOMIDE IN PATIENTS WITH EGFR-AMPLIFIED NEWLY DIAGNOSED GBM Conference Paper uri icon

authors

  • Wefel, Jeffrey S
  • Won, Minhee
  • Lassman, Andrew
  • Stern, Yaakov
  • Wang, Tony
  • Aldape, Kenneth
  • Armstrong, Terri
  • Vogelbaum, Michael
  • Sulman, Erik
  • Moazami, Golnaz
  • Macsai, Marian
  • Gilbert, Mark
  • Bain, Earle
  • Blot, Vincent
  • Gan, Hui
  • Preusser, Matthias
  • Ansell, Peter
  • Samanta, Suvajit
  • Kundu, Madan
  • Seidel, Clemens
  • de Vos, Filip
  • Hsu, Sigmund
  • Cardona, Andres
  • Lombardi, Giuseppe
  • Bentsion, Dmitry
  • Peterson, Richard
  • Gedye, Craig
  • Lebrun-Frenay, Christine
  • Wick, Antje
  • Pugh, Stephanie
  • Curran, Walter
  • Mehta, Minesh

publication date

  • November 1, 2020